BCTXW
Closed
Briacell Therapeutics Corp
0.0735
-0.0018 (-2.39%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.0753
Day's Range: 0.04 - 0.0752
Send
sign up or login to leave a comment!
When Written:
2.96
BriaCell Therapeutics Corp is a clinical-stage biotechnology company that develops innovative immunotherapy treatments for cancer. The company's lead product candidate, Bria-IMT, is a personalized immunotherapy that targets advanced breast cancer. BriaCell's approach involves using a patient's own tumor cells to create a personalized vaccine that stimulates the immune system to attack cancer cells. The company is also developing a second product candidate, Bria-OTS, which is an off-the-shelf version of Bria-IMT that can be used for a broader range of cancer patients. BriaCell is headquartered in Berkeley, California, and has research and development operations in Vancouver, Canada. The company is publicly traded on the NASDAQ under the ticker symbol BCTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








